Trials / Completed
CompletedNCT01765452
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Multi-center, Randomized, Open Study for Comparison of Efficacy and Safety of Plavix With Astrix and Closone in Patients With Post-Percutaneous Coronary Artery Intervention
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 285 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The Aim of this study is to prove non-inferiority of Closone to the Combination treatment of Plavix with Astrix.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Closone | 75mg/100mg, 8weeks, PO |
| DRUG | Plavix with Astrix | 75mg, 100mg a day, 8weeks, PO |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2013-01-10
- Last updated
- 2014-05-12
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01765452. Inclusion in this directory is not an endorsement.